Recode Studios Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Recode Studios Ltd is ₹ 422.75 as of 23 Oct 15:30 . The P/E Ratio of Recode Studios Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Recode Studios Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Recode Studios Ltd for the Mar '26 is ₹ 22.61 crore as compare to the Dec '25 revenue of ₹ 20.49 crore. This represent the growth of 10.35% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.46 crore. This represent the decline of -100% The ebitda of Recode Studios Ltd for the Mar '26 is ₹ 3.25 crore as compare to the Dec '25 ebitda of ₹ 7.44 crore. This represent the decline of -56.32% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 ebitda of ₹ 1.43 crore. This represent the decline of -3586% The net profit of Recode Studios Ltd changed from ₹ 2.35 crore to ₹ 2.16 crore over 4 quarters. This represents a CAGR of -8.09% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ -49.86 crore over 8 quarters. This represents a CAGR of 1110.98% The Dividend Payout of Recode Studios Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Recode Studios Ltd

Recode Studios Limited was originally incorporated as 'Recode Studio Private Limited' on June 16, 2021, pursuant to a Certificate of Incorporation issued by Registrar of Companies, Punjab.
Thereafter, Company was converted from private limited to public limited on September 16, 2025.
Company is engaged in the business of beauty and cosmetics products. The business of the Company involve mainly the branding, procurement and distribution of beauty and personal care products.
It offer a diversified portfolio of products across make-up, skincare, body care and beauty accessories, catering to a wide range of consumer preferences and usage occasions. The 'Recode' brand was established in 2018 under the partnership firm, M/s Lush Looks, by five of the existing Promoters.
Subsequent to the incorporation of the Company in 2021, the business operations of M/s Lush Looks were gradually transferred to Company and by the end of the financial year 2022-23, the entire business was being carried on by the Company.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Recode Studios Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Recode Studios Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Recode Studios Ltd is 449 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Recode Studios Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Recode Studios Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Recode Studios Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Recode Studios Ltd stock price is INR ₹422.75. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Recode Studios Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Recode Studios Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.